The nation of Zimbabwe has rejected a major American health deal worth $367m (272 million pounds) spanning five years due to Washington's insistence on sensitive information.
This move became public after a official document dated December was leaked, indicating that President Emmerson Mnangagwa deemed the deal was "unbalanced".
A government representative later stated that the United States was demanding access to health data for research and profit while was not willing to share the resulting advantages from future treatments.
"We must now begin the challenging and unfortunate process of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for further negotiations to reach a deal suitable to all parties so the country's vital HIV treatment initiative can be sustained.
Wider Context
This rejection follows a similar case in neighbouring Kenya, where a high court blocked a related deal with the US after legal challenges were raised about the safety of Kenyans' health data.
Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had managed assistance for the American government, but Trump argued its expenditure was "wasteful" and his government was seeking government-to-government deals to boost openness and responsibility.
As per reports, 16 nations in Africa have to date agreed to these new agreements, constituting over $18.3bn in new funding.
Details of the Rejected Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information over an extended period, without any corresponding guarantee of benefiting from any medical innovations – like new medicines or tests – that might result from that provided information," Mangwana explained.
"In essence, our country would supply the basic resources for medical research with no certainty that the resulting innovations would be available to our citizens should a new disease outbreak arise."
National Interest and Global Health
Mangwana further said that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting structures previously established through the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.
"This mechanism is intended to ensure that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."
These objections regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage continued dialogue with our US partners on how future co-operation might be designed in a manner that honours the independence and interests of each country."
Medical Community Reaction
A leading public health body expressed it recognised the official position, but recommended that negotiations must proceed considering much of the nation's Aids initiatives relied on external financing.
"Where specific concerns arise, including those involving information security or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," it commented.
The situation emphasises the continuing tensions between accepting much-needed international aid and protecting a country's data in an ever more interconnected world.